Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: DiaMedica Therapeutics Inc., 3 years.
DiaMedica Therapeutics Inc.
Director
Oncolytics Biotech Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
DiaMedica Therapeutics Inc. May 20, 202697.0%
-
DiaMedica Therapeutics Inc. May 15, 202596.9%
-
DiaMedica Therapeutics Inc. May 22, 202497.6%
-
DiaMedica Therapeutics Inc. May 17, 202394.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +10,000 | $1.03 | $10,300 |
| Jan 2, 2026 | DiaMedica Therapeutics Inc. | Grant or award | +10,095 | $8.42 | $85,000 |
| Nov 21, 2025 | DiaMedica Therapeutics Inc. | Option exercise | +12,000 | $2.20 | $26,400 |
| Jan 2, 2025 | DiaMedica Therapeutics Inc. | Grant or award | +15,917 | $5.34 | $84,997 |
| Jan 2, 2024 | DiaMedica Therapeutics Inc. | Grant or award | +21,428 | $2.80 | $59,998 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.